High viral load is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis B virus infection.
about
Epidemiology and Prevention of Hepatitis B Virus InfectionRisk Factors and Post-Resection Independent Predictive Score for the Recurrence of Hepatitis B-Related Hepatocellular CarcinomaHepatitis B-associated fibrosis and fibrosis/cirrhosis regression with nucleoside and nucleotide analogs.Adherence to chronic hepatitis B treatment guideline recommendations for laboratory monitoring of patients who are not receiving antiviral treatment.Pre-S deletion and complex mutations of hepatitis B virus related to young age hepatocellular carcinoma in Qidong, China.Occult HBV infection among Egyptian hepatocellular carcinoma patients.Clinical analysis of the risk factors for recurrence of HCC and its relationship with HBV.Hepatocellular carcinoma in Egypt: a single center study over a decade.He Jie Tang in the treatment of chronic hepatitis B patients.High hepatitis B virus load is associated with hepatocellular carcinomas development in Chinese chronic hepatitis B patients: a case control study.Expression of AIM2 is correlated with increased inflammation in chronic hepatitis B patients.Screening for hepatocellular carcinoma by Egyptian physicians.Long-Term Telbivudine Treatment Results in Resolution of Liver Inflammation and Fibrosis in Patients with Chronic Hepatitis B.Comparable efficacy with entecavir monotherapy and tenofovir-entecavir combination in chronic hepatitis B patientsOptimizing management strategies in special patient populations.Baseline prognostic factors and statistic model to predict early virological response in lamivudine-treated patients with chronic hepatitis B.Basal core promoter T1762/A1764 and precore A1896 gene mutations in hepatitis B surface antigen-positive hepatocellular carcinoma: a comparison with chronic carriers.The evolving role of leptin and adiponectin in chronic liver diseases.Hepatitis B virus genetic variants: biological properties and clinical implicationsHBV A1762T, G1764A mutations are a valuable biomarker for identifying a subset of male HBsAg carriers at extremely high risk of hepatocellular carcinoma: a prospective study.A case-control study of the relationship between hepatitis B virus DNA level and risk of hepatocellular carcinoma in Qidong, China.Baseline prognostic factors and statistic model to predict early virological response in telbivudine-treated patients with chronic hepatitis B.Safety evaluation of telbivudine.Advanced mass spectrometry-based multi-omics technologies for exploring the pathogenesis of hepatocellular carcinoma.Antioxidant and cytotoxic activity of polyphenolic compounds isolated from the leaves of Leucenia leucocephala.Cost-effectiveness analysis of entecavir versus lamivudine in the first-line treatment of Australian patients with chronic hepatitis B.Human Schistosomiasis mansoni associated with hepatocellular carcinoma in Egypt: current perspectiveHepatitis B virus core promoter mutations in patients with chronic hepatitis B and hepatocellular carcinoma in bucharest, romania.HBV Subgenotype C2 Infection, A1762T/G1764A Mutations May Contribute To Hepatocellular Carcinoma with Cirrhosis in Southeast China.Role of lamivudine with transarterial chemoembolization in the survival of patients with hepatocellular carcinoma.A long-term follow-up and comprehensive observation of risk and prognosis factors of recurrence and survival after resection of hepatocellular carcinoma.Hepatitis B virus infection in clustering of infection in families with unfavorable prognoses in northwest China.Histological improvement of long-term antiviral therapy in chronic hepatitis B patients with persistently normal alanine aminotransferase levels.Long-term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B.Risk of hepatocellular carcinoma in patients with chronic hepatitis B virus infection.A population-based cohort study for the risk factors of HCC among hepatitis B virus mono-infected subjects in Japan.Lower serum viral loads in young patients with hepatitis-B-virus-related hepatocellular carcinoma.Deciphering hepatocellular carcinoma through metabolomics: from biomarker discovery to therapy evaluation.
P2860
Q24810152-9FE0B199-BF2F-4CAA-A394-BD3F0743015FQ28550305-4579EAFF-478B-4C60-BD2D-092FBA056D22Q34257596-B327E96F-603C-4307-A1E8-75B7DBC9201EQ34594451-C21F303F-2B47-49F0-96FB-7DE413C7439FQ34651625-7611DF6A-0727-42DB-B90D-3D3C6BBBD8CFQ34677661-5AD56F65-97BD-40B5-BD60-87C027DA9725Q35010687-9658EDC5-F0CB-4DD4-8AE9-287328CB1864Q35059721-A5ECEE30-890B-411A-84A0-5263F683E338Q35165863-6457F8A6-6712-4429-A2C8-77C39B2EFB17Q35950941-D6D27C58-190F-4CAF-B29D-98038E8073E8Q35986253-FC389546-9E69-41AF-B551-8953DD89C318Q36059063-780408E5-99B1-41ED-9319-A0FAB5EFC406Q36067389-6984F434-5576-479E-B04F-5A9F817F4675Q36140470-6BB7C079-107F-4FEB-9D2D-1AD7944B01BCQ36382644-0648CEB6-E73F-452B-B8AC-40F84ABDAA56Q36412205-CB2A9C5B-00A1-4D0E-9181-83B3E6B3D019Q36436879-BFA0A229-9859-4D46-B426-9E2A6238EB95Q36585280-4A19CF3E-4346-4EBB-A4FF-1CCCF066A97CQ36795324-D7A3CA3A-678A-4F3E-A34E-1421764DAC7EQ36935260-96E80227-05F1-42E9-98FC-BB6D6ACC2C79Q37265609-FD5A6C64-1C1F-43BF-9BFE-EEBE4048AFD2Q37424359-8E2EEF6C-2374-4D05-99D4-9EE07D872D97Q37775959-2D8B475C-844B-49F5-9C1B-666FA817E622Q38217062-155BA261-EB3C-44B0-81CD-FC73673CF1C9Q39041125-7863A956-31C9-41BE-BF44-5C0AC6A945ACQ40140066-45F8FDF9-35F2-4619-BD3E-691D1ABD5671Q40403286-6258FE17-1318-43C4-9757-F07AEB657F49Q41615602-EB986B3E-1217-4B40-BDC8-B798A348C72EQ41882762-B79F799C-56A2-4CF6-9B17-588A5DB835AFQ42210690-E7FEA79A-C40B-42B3-A806-619FD9DD1B73Q42224788-5FC3CCE6-F2C2-4649-9987-411007A0C09DQ42251541-1CA08CEE-D019-489D-B3C1-C0C49A96BD06Q42267688-CCD94131-BB2E-4946-9933-9C80B1FF3327Q42947269-A669C19C-B9F1-4A8F-A077-E6CCB687B931Q43185894-3AB91DBF-D14C-44F8-B4AA-173AF973D986Q45373255-4B6F8F62-44C5-464C-B288-D6B5F13BF80EQ45407126-DCA70B87-9611-4875-8119-173C274A0F9CQ52564715-D92D2F45-CED6-48FA-87F4-1C2D026F3219
P2860
High viral load is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis B virus infection.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
High viral load is a risk fact ...... c hepatitis B virus infection.
@en
High viral load is a risk fact ...... c hepatitis B virus infection.
@nl
type
label
High viral load is a risk fact ...... c hepatitis B virus infection.
@en
High viral load is a risk fact ...... c hepatitis B virus infection.
@nl
prefLabel
High viral load is a risk fact ...... c hepatitis B virus infection.
@en
High viral load is a risk fact ...... c hepatitis B virus infection.
@nl
P2093
P2860
P921
P1476
High viral load is a risk fact ...... c hepatitis B virus infection.
@en
P2093
Hiroki Ishikawa
Kan Toriyama
Katsumi Eguchi
Kazuhiko Nakao
Kazuyuki Ohata
Keisuke Hamasaki
P2860
P304
P356
10.1111/J.1440-1746.2004.03360.X
P577
2004-06-01T00:00:00Z